Lead Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Collaborators

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Patients of both sexes.
•Over 18 years.
•Confirmation of SARS-COV-2 infection by RT-PCR in respiratory sample.
•Respiratory failure requiring intubation and connection to mechanical ventilation, secondary to SARS-CoV-2 infection.
•Criteria for acute respiratory distress: acute bilateral alveolar-interstitial infiltrate not compatible with left ventricular failure (demonstrated with ultrasound or hemodynamic parameters), sudden onset, and blood gas compromise with a PaO2 / FiO2 ratio \<200 mm-Hg.
•Women of childbearing potential should have a negative urine pregnancy test performed at the time of study enrollment.
•Written or verbal informed consent from the patient, family member or legal representative.

•Any other cause of acute respiratory distress not attributable to SARS-Cov-2.
•RT-PCR of SARS-Cov-2 negative.
•Multi-organ failure (more than three organs)
•Severe respiratory failure requiring extracorporeal support (ECMO) Grave Moderate severe COPD requiring chronic home oxygen therapy, need for prior home oxygen therapy for any reason.
•Pregnancy, lactation and women of childbearing age but who do not take effective contraceptive measures.
•Active tumor disease.
•Previous immunosuppressive treatment.
•Allergy or hypersensitivity to the administered products.
•History of deep vein thrombosis or pulmonary embolism in the last 3 years.
•Participation in other clinical trials during the 3 months prior to the initial visit.

Related studies

NCT07261787 · Neonates and Preterm Infants, Infant Respiratory Distress Syndrome, and more

NCT07251790 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

BAttLe Against COVID-19 Using MesenchYmal Stromal Cells